| Application no. and date | 17710208.4 (espacenet) (Federated) (European Patent Register), 20170309 | | Patent/reg. no. and date | DK/EP 3426294, 20230517 | | Publication date | 20190116 | | Priority no. and date | GB 201604124, 20160310 | | EP pub. no. and date |
EP 3426294 20190116 | | Effective date | | | Applicant/owner | UCB Biopharma SRL, Allée de la Recherche 60
1070 Brussels, BE | | Applicant ref. no. | V461138DK00 | | Inventor | YATES, Andrew Jeffrey, c/o UCB Australia Pty. Ltd
1155 Malvern Road
Victoria 3144, AU,
CLIPSTONE, James Gregory, c/o UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/18 (2017.01) , A61K 47/20 (2006.01) , A61K 47/40 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 19/08 (2006.01) , A61P 19/10 (2006.01) , A61P 29/00 (2006.01) , C07K 16/22 (2006.01) | | Title | Farmaceutisk formulering omfattende antistof, cyclodextrin og methionin | | Int. application no. | EP2017055594 | | Int. publication no. | WO2017153541 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
